Multiplex Assays Market Report 2026

Multiplex Assays Market Overview

• Multiplex Assays market size has reached to $3.88 billion in 2025 • Expected to grow to $5.75 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Rising Incidence Of Chronic Diseases Propels Growth In The Global Multiplex Assay Market • Market Trend: Euro Fins Technologies Elevates Diagnostic Capabilities With Launch Of Multiplex RT-PCR Assays For Respiratory Diseases • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Multiplex Assays Market?

Multiplex assays are used to amplify multiple targets in a polymerase chain response (PCR) trial and collect further information from nanosecond amounts of proteins or other analyses in lower time as compared to the conventional system, similar to ELISA. Multiplex assays are used for pathogen identification, mutation analysis, RNA discovery, gene discovery analysis, relation analysis, forensic studies, and others. The main types of multiplex assays include nucleic acid-based multiplex assays, protein-based multiplex assays, and others. Nucleic acid-based multiplex assays are based on nucleic acids to detect organism-specific DNA or RNA sequences. These tests are generally specific and highly sensitive, and the results can be provided rapidly. The different multiplex assay technologies include flow cytometry, luminescence, fluorescence detection, multiplex real-time PCR, and other technologies. Multiplex assays are used for various applications such as research and development, and clinical diagnostics by end-users including pharmaceutical and biotechnology companies, hospitals and research institutes, reference laboratories, and other end-users.

What Is The Multiplex Assays Market Growth Forecast?

The multiplex assays market size is expected to see strong growth in the next few years. It will grow to $5.75 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to advancements in multiplex technologies, rising clinical diagnostic adoption, increasing application in precision medicine, expanding use in forensic laboratories, growth in genetic mutation analysis demand. Major trends in the forecast period include growing adoption of multiplex pcr for pathogen detection, rising use of multiplex assays in mutation and gene analysis, increasing demand for high-throughput protein quantification, expansion of multiplex platforms in clinical diagnostics, enhanced application of multiplex assays in forensic and research studies.

Global Multiplex Assays Market Segmentation

1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types 2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies 3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies 4) By Application: Research And Development, Clinical Diagnostics 5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users Subsegments: 1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay), Luminex xMAP Technology, Western Blotting, Immunohistochemistry, Mass Spectrometry-Based Assays 2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction), qPCR (Quantitative PCR), NGS (Next-Generation Sequencing), Microarray Analysis, RT-PCR (Reverse Transcription PCR) 3) By Other Types: Cell-Based Multiplex Assays, Bioanalytical Assays, Imaging-Based Assays, Surface Plasmon Resonance (SPR) Assays

What Is The Driver Of The Multiplex Assays Market?

An increasing incidence of chronic diseases is expected to drive the growth of the global multiplex assay market going forward. Chronic diseases are long-lasting medical conditions that progress slowly over time and typically require ongoing management, often affecting multiple organ systems and overall quality of life. A key factor driving the increasing incidence of chronic diseases is the aging population, as advancing age heightens physiological vulnerability, reduces regenerative capacity, and lengthens exposure to cumulative risk factors, thereby making individuals more susceptible to the development and progression of long-term health conditions. Multiplex assays enable simultaneous measurement of multiple biomarkers, supporting earlier detection, more precise disease monitoring, and improved clinical decision-making for individuals managing chronic diseases. For instance, in April 2024, according to Allergy UK, a UK-based national charity, more than 21 million people in the UK are affected by allergies, which became the most commonly reported chronic health condition in 2022, and projections indicate that by 2026, half of Europe's population will experience at least one allergy. Therefore, the increasing incidence of chronic diseases is driving the multiplex assay industry.

Key Players In The Global Multiplex Assays Market

Major companies operating in the multiplex assays market are Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

Global Multiplex Assays Market Trends and Insights

Major companies operating in the multiplex assays market are focusing on developing innovative advancements such as ultrasensitive multiplexed digital PCR assays to improve mutation detection accuracy and support more efficient clinical research workflows. Ultrasensitive multiplexed digital PCR assays refer to high-precision analytical tools capable of detecting and quantifying multiple low-abundance genetic variants within a single reaction, enhancing sensitivity while reducing sample consumption and testing time. For example, in January 2024, Bio-Rad Laboratories Inc. a US-based life science research and clinical diagnostic products company launched the ddPLEX ESR1 Mutation Detection Kit, which is the first ultrasensitive multiplexed digital PCR assay specifically designed for detecting breast cancer mutations in clinical research. The assay enables simultaneous detection and quantification of seven known relevant ESR1 mutations in a single well, streamlining the testing process. It boasts an analytical sensitivity down to 0.01% variant allele fraction (VAF), allowing for the detection of low-frequency mutations that may be critical in cancer diagnostics. The kit can be used with circulating tumor DNA (ctDNA) from plasma or DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissue samples, providing flexibility in sample types for testing.

What Are Latest Mergers And Acquisitions In The Multiplex Assays Market?

In May 2025, Vizgen, Inc., a US-based provider of spatial multi-omics platforms, partnered with Hamamatsu Photonics K.K. to integrate multiplex immunofluorescence imaging with advanced multiplex assay chemistry. Through this collaboration, the companies aim to streamline spatial biology workflows by combining Vizgen’s high-fidelity InSituPlex multiplex assays with Hamamatsu’s MoxiePlex multiplex immunofluorescence imaging system, creating a seamless end-to-end solution for translational and clinical biomarker research. Hamamatsu Photonics K.K. is a Japan-based technology company specializing in advanced optical imaging systems, including high-throughput, nine-color multiplex immunofluorescence platforms.

Regional Outlook

North America was the largest region in the multiplex assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Multiplex Assays Market?

The multiplex assays market consists of sales of equipment with technologies that can detect multiple genes such as flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies in multiplex assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Multiplex Assays Market Report 2026?

The multiplex assays market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex assays industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.